glp-1 and hrt Hormone Replacement Therapy Medications What to know when using

Available from: GBD 2021 Diabetes Collaborators (2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

74 VadiniF.SimeoneP.BoccatondaA.GuagnanoM.LianiR.TripaldiR.et al (2020)

Semaglutide for Prediabetes Prevention: The Clinical Case How semaglutide prevents the progression from prediabetes to type 2 diabetes clinical evidence, A1C improvements, and insulin restoration

Your healthcare professional can offer the right assistance, but doing proper research and knowing the basics can help

Arch Intern Med 2012

Discussion To our knowledge, the findings of this study provide some of the first evidence that, among individuals with T2D, the use of GLP-1 RAs was associated with a lower risk of sight-threatening complications, including PDR, DME, and neovascular glaucoma, despite a marginally increased incidence of any DR